Association Between Unstable Angina and CXCL17: a New Potential Biomarker

Fu-Han Gong1, Xiao-Qiang Xiao1, Xue-Ping Zhang1

  • 1Department of Cardiology, Tongren Municipal People's Hospital, No.120 Taoyuan Avenue, Chuandong Education park, Bijiang District, Tongren City 554300, China.

Insights

Elevated serum CXCL17 levels are linked to unstable angina, suggesting this chemokine may serve as a novel biomarker for coronary heart disease instability and inflammation.

Area of Science:

  • Cardiovascular Medicine
  • Immunology
  • Biochemistry

Background:

  • Chemokines play a role in atherosclerosis.
  • The specific role of chemokine CXCL17 in the development of atherosclerosis (atherogenesis) remains unclear.
  • Investigating CXCL17's involvement in coronary heart disease (CHD) is crucial.

Purpose of the Study:

  • To measure serum CXCL17 levels in patients with different stages of coronary heart disease (CHD).
  • To determine if CXCL17 levels correlate with atherosclerosis severity and inflammatory markers.
  • To explore CXCL17 as a potential biomarker for unstable angina (UA).

Main Methods:

  • Prospective study involving 48 unstable angina (UA) patients, 51 stable angina (SA) patients, and 41 controls (CG).
  • Coronary angiography for diagnosis and Gensini score for disease severity.
  • Enzyme-linked immunosorbent assay (ELISA) for CXCL17 levels; automated analyzer for lipid profiles and high-sensitivity C-reactive protein (hs-CRP).

Main Results:

  • Unstable angina (UA) patients exhibited significantly higher serum CXCL17 levels than stable angina (SA) patients and controls (CG).
  • Logistic regression identified CXCL17 as an independent risk factor for UA.
  • CXCL17 levels correlated positively with hs-CRP, indicating a link to inflammation, but not with the Gensini score.

Conclusions:

  • Elevated serum CXCL17 is associated with unstable angina (UA), suggesting a role in atherosclerotic plaque instability.
  • CXCL17 may serve as a potential new biomarker for identifying unstable angina (UA).
  • CXCL17's association with hs-CRP highlights its connection to inflammatory responses in cardiovascular disease.

Related Concept Videos

Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
165
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
479
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
159
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
301
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
715
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
228